Skip to main content
Top

International Journal of Hematology

Issue 2/2022

Content (19 Articles)

Images in Hematology

Green–blue inclusions in neutrophils and monocytes: a critical finding

Daniel Welder, Weina Chen

Venous Thrombosis Rapid Communication

Isolated thrombosis after COVID-19 vaccination: case series

Mona Al-Ahmad, Mona Al Rasheed, Lulwa Altourah, Tito Rodriguez-Bouza, Neveen Shalaby

Fluconazole Rapid Communication

Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal

Toshihisa Nakashima, Yoshihiro Inamoto, Jun Aoki, Ayumu Ito, Takashi Tanaka, Sung-Won Kim, Hironobu Hashimoto, Takahiro Fukuda, Tetsuya Furukawa

Hemophilia Original Article

Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan

Masahiro Takeyama, Kana Sasai, Tomoko Matsumoto, Shoko Furukawa, Kenichi Ogiwara, Koji Yada, Tomoko Onishi, Midori Shima, Keiji Nogami

Hemophilia Original Article

Coagulation assay discrepancies in Japanese patients with non-severe hemophilia A

Hiroshi Inaba, Satomi Nishikawa, Keiko Shinozawa, Sho Shinohara, Fumie Nakazawa, Kagehiro Amano, Ei Kinai

Acute Myeloid Leukemia Original Article

Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients

Akio Mori, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama, Toru Miyajima, Emi Yokoyama, Reiki Ogasawara, Koh Izumiyama, Makoto Saito, Shinichi Fujisawa, Shuichi Ota, Yasutaka Kakinoki, Yutaka Tsutsumi, Satoshi Yamamoto, Takuto Miyagishima, Takahiro Nagashima, Hiroshi Iwasaki, Hajime Kobayashi, Yoshihito Haseyama, Mitsutoshi Kurosawa, Masanobu Morioka, Takanori Teshima, Takeshi Kondo

Primary Myelofibrosis Original Article

Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice

Noriyuki Saito, Takuji Yamauchi, Noriaki Kawano, Rintaro Ono, Shuro Yoshida, Toshihiro Miyamoto, Tomohiko Kamimura, Leonard D. Shultz, Yoriko Saito, Katsuto Takenaka, Kazuya Shimoda, Mine Harada, Koichi Akashi, Fumihiko Ishikawa

Thrombosis Original Article

Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study

Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, Hideho Wada, Kensuke Usuki, Takayuki Tanaka, Takehiko Mori, Satoshi Wakita, Toshiki I. Saito, Akiko Kada, Akiko M. Saito, Kazuya Shimoda, Yuka Sugimoto, Toshiro Kurokawa, Akihiro Tomita, Yoko Edahiro, Koichi Akashi, Itaru Matsumura, Katsuto Takenaka, Norio Komatsu

Rituximab Original Article

Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

Grzegorz S. Nowakowski, Wolfgang Willenbacher, Richard Greil, Thomas S. Larsen, Krish Patel, Ulrich Jäger, Robert F. Manges, Lorenz Trümper, Hele Everaus, Nagesh Kalakonda, Peter Brown, Judit Meszaros Jørgensen, David Cunningham, Justine Dell’Aringa, Brian Fox, Neus Domper Rubio, Nurgul Kilavuz, Marie-Laure Casadebaig, Oliver Manzke, Javier Munoz

Multiple Myeloma Original Article

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

Rikio Suzuki, Yuka Kitamura, Daisuke Ogiya, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando

Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI

Yuta Yamada, Shuntaro Ikegawa, Yuho Najima, Yuya Atsuta, Ryosuke Konuma, Hiroto Adachi, Atsushi Wada, Yuya Kishida, Tatsuya Konishi, Akihito Nagata, Satoshi Kaito, Ryohei Nagata, Yuma Noguchi, Atsushi Marumo, Junichi Mukae, Kyoko Inamoto, Takashi Toya, Aiko Igarashi, Takeshi Kobayashi, Hisashi Sakamaki, Kazuteru Ohashi, Noriko Doki

Splenectomy Original Article

Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report

Abhilasha Sampagar, Manasi Gosavi, Prabhakar Kedar, Taiseenub Patel, Rashmi Dongerdiye, Niranjana Mahantashetti

Leukemia Original Article

A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia

Yuko Honda, Hideki Muramatsu, Yuka Nanjo, Shinsuke Hirabayashi, Toru Meguro, Nao Yoshida, Harumi Kakuda, Shuichi Ozono, Manabu Wakamatsu, Hiroshi Moritake, Masahiro Yasui, Hideki Sano, Atsushi Manabe, Kazuo Sakashita

Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children

Akihisa Sawada, Mariko Shimizu, Maho Koyama-Sato, Kohei Higuchi, Yosuke Okada, Kimitoshi Goto, Shota Inoue, Masahiro Yasui, Masami Inoue

NUDT15 genetic testing-guided 6-mercaptopurine dosing in children with ALL likely to be cost-saving in China

XiaoXia Wei, Jing Zhuang, Na Li, Bin Zheng, Hong Sun, JiaQin Cai, Xuhui Huang, Guifeng Zhang, Jie Zhuang

Utility of 18F-FDG-PET for detecting acute lymphoblastic leukemia: a case series of pediatric acute lymphoblastic leukemia without hematological symptoms

Yasuhiro Ikawa, Mika Takenaka, Yuta Sakai, Kazuhiro Noguchi, Masaki Fukuda, Toshihiro Fujiki, Rie Kuroda, Shintaro Mase, Raita Araki, Hideaki Maeba, Ryosei Nishimura, Akihiro Yachie, Taizo Wada

Petechiae Letter to the Editor

Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual

Asuka Ogai, Ryuto Yoshida, Chiaki Yuasa, Kenko Chin, Katsumichi Fujimaki, Hideaki Nakajima

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine